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Exploring the requirements and regulation of anillin as a target of the chromatin pathway 





This thesis explores the requirement of anillin, a cytokinesis regulator, in different human 
cell types and the mechanism that regulates anillin function. Cytokinesis is the process that 
physically separates a cell into two daughter cells. It takes place during mitotic exit to complete 
the cell cycle. Cytokinesis is spatiotemporally controlled to ensure that each daughter cell inherits 
the proper distribution of genomic and cytoplasmic content.  Dysregulation of cytokinesis is 
correlated with diseases such as cancer. In metazoan cells, cytokinesis relies on the assembly and 
ingression of an actomyosin ring that pinches in the overlying membrane. Anillin is a scaffold 
protein with multiple binding partners that crosslinks the actomyosin ring to the membrane. 
Multiple conserved mechanisms regulate cytokinesis, and some mechanisms may be favored 
over others depending on the cell type. Our lab recently discovered a chromatin-based pathway 
that regulates ring assembly and position through anillin. We propose that this pathway is more 
strongly required in cancer cells with high aneuploidy, which typically arises during cancer 
progression. In support of this model, we found that anillin depletion causes a higher incidence 
of cytokinesis failure in cancer cells with higher aneuploidy. Using CRISPR-Cas9 to endogenously 
tag anillin, we define the thresholds of anillin required to support cytokinesis in different cell 
types. We also explored the mechanism regulating anillin function, and found that the chromatin 
pathway controls phospholipid binding required for the cortical recruitment of anillin. My 
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Chapter 1. Introduction 
1.1 Cytokinesis Overview 
 
The assembly and ingression of the contractile ring is the fundamental driving force of 
cytokinesis (Glotzer, 2017; Pollard, 2017; Figure 1; Figure 2). In animal cells, the first visible 
component of the contractile ring is the enrichment of active RhoA in the equatorial plane during 
anaphase. This pool of active RhoA is generated by the guanine nucleotide exchange factor (GEF) 
Ect2, while RhoA is downregulated at other regions of the cortex by MP-GAP (Figure 2). Active 
RhoA binds to multiple effectors including formin and Rho kinase for actomyosin filament 
assembly that leads to force generation through constriction (Basant & Glotzer, 2018; Piekny et 
al., 2005). RhoA also recruits anillin to the equatorial plane (Piekny & Glotzer, 2008; Figure 1). 
Anillin is a highly conserved contractile ring protein with binding sites for actin, myosin, RhoA, 
phospholipids, microtubules and septins, among others, and crosslinks actomyosin to the overlying 
plasma membrane for ring positioning (Green et al., 2012; Piekny & Glotzer, 2008; Piekny & 
Maddox, 2010). Anillin stabilizes RhoA at the equatorial cortex (Beaudet et al., 2020; Budnar et 
al., 2019; Figure 2). It also regulates the maturation of the contractile ring to the midbody ring, 
which requires the shedding of membrane and ring components to form a stable midbody that is 
required for abscission (El Amine et al., 2013; Kechad et al., 2012).  
Regulators that mediate ring assembly and constriction are essential to support cytokinesis. 
Specifically, the loss of key regulators, including Ect2, RhoA, formin or Rho kinase causes early 
cytokinesis phenotypes in metazoan cells including those in C. elegans, Drosophila, Xenopus, and 
mammals (Piekny et al., 2005; Piekny & Glotzer, 2008; Reyes et al., 2014; Yüce et al., 2005). In 
these cells, the ring fails to form, or forms but fails to ingress. In anillin-depleted cells, the ring 
either ingresses more symmetrically vs. asymmetrically (e.g. early C. elegans embryo), or its 
position is not stable and the ring oscillates around the cell (Drosophila S2 cells, or HeLa cells) 
(Maddox et al., 2007; Piekny & Glotzer, 2008; Straight et al., 2005). However, anillin depletion 
also causes later cytokinesis phenotypes consistent with its role in midbody ring transition (Kechad 








Figure 1. An overview of cytokinesis. Cytokinesis occurs at the end of mitosis to physically 
separate the daughter cells. A. In anaphase onset, signals establish the division plane, where 
distribution of cytokinesis regulators take place. Specifically, the central spindle microtubules start 
to bundle (pink) between segregated chromosomes (blue) in addition to the localization of other 
core cytokinesis regulators. One of the regulators is anillin, which gets recruited to the equatorial 
cortex (green). B. The assembly and ingression of an actomyosin ring leads to furrow ingression 
of the overlying membrane to pinch in the daughter cells (green). C. The contractile ring transitions 
into a midbody ring and initiates abscission that leads to the physical separation of the daughter 





















































Figure 2. Cytokinesis regulators mediate ring assembly and ingression. Spindle dependent and 
-independent pathways regulate cytokinesis. Cytokinesis is initiated through activation of the 
master regulator RhoA-GTP. Specifically, centralspindlin activates Ect2 (RhoA GEF). This in turn 
activates RhoA-GTP, which activates anillin, actin, and myosin to initiate contractile ring 
assembly and constriction. Anillin stabilizes active RhoA at the equatorial cortex. Concurrently, 





































Multiple spindle dependent and -independent pathways work together to regulate 
contractile ring assembly or positioning (Figure 2). In animal cells, the anaphase spindle has 
associated signals that controls the position and assembly of the actomyosin ring (Fededa & 
Gerlich, 2012; Green et al., 2012; Pollard & O’Shaughnessy, 2019). Signals associated with other 
locations and organelles including chromatin, centrosomes and kinetochores also influence ring 
positioning or ingression kinetics (Beaudet et al., 2017; Kiyomitsu & Cheeseman, 2013; Mangal 
et al., 2018; Rodrigues et al., 2015; Zanin et al., 2013). The requirement of a pathway likely varies 
among cell types depending on characteristics such as cell size, symmetry, ploidy and fate. 
However, some of the spindle-independent pathways are newly discovered and are not well-
understood, and few studies have explored the regulation of cytokinesis in vivo. 
 
1.2 Spindle-dependent pathways  
The division plane is spatially defined by the anaphase spindle, which is composed of the 
central spindle and astral microtubules. The central spindle forms in anaphase, and consists of 
antiparallel bundled microtubules that arise between the segregating chromosomes (Mishima et 
al., 2002, 2004). Centrosome-derived astral microtubules emanate toward the cell poles. Proteins 
associated with the central spindle and/or astral microtubules control the breadth of active RhoA 
in the equatorial cortex, which is initially broad, but then becomes narrower as the ring ingresses 
(Basant et al., 2015; D’Avino et al., 2015; Fededa & Gerlich, 2012; Yüce et al., 2005; Zanin et al., 
2013).  
The central spindle is associated with the generation of active RhoA (Figure 3). 
Centralspindlin is a heterotetrametric complex that is composed of dimers of the kinesin motor 
MKLP1 and Cyk4/MgcRacGAP, and is essential for central spindle assembly in metazoan cells 
(Glotzer, 2009; Mishima et al., 2002, 2004; Pavicic-Kaltenbrunner et al., 2007). In addition, Cyk4 
forms an anaphase-dependent complex with Ect2 that is required to generate active RhoA (Basant 
& Glotzer, 2018; Kotýnková et al., 2016; Lekomtsev et al., 2012; Yüce et al., 2005). This is 
accomplished by the interplay between Cdk1, Polo-like kinase 1 (Plk1), and Aurora B kinase 
(Basant et al., 2015; Hara et al., 2006; Niiya et al., 2006; Petronczki et al., 2007; Wolfe et al., 
2009). The inactivation of Cdk1 at mitotic exit corresponds with the dephosphorylation of Ect2, 
presumably to relieve its autoinhibition of the C-terminal DH domain which is required for 
nucleotide exchange (Fededa & Gerlich, 2012; Hara et al., 2006; Yüce et al., 2005). Concurrently, 
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phosphorylation of Cyk4 by Plk1 is required for Ect2-binding and to facilitate GEF activity, 
although how Cyk4-binding modulates GEF activity is not known (Adriaans et al., 2019; Niiya et 
al., 2006; Petronczki et al., 2007; Wolfe et al., 2009). The depletion or loss-of-function alleles of 
Cyk4 and Ect2 have the same phenotype, where active RhoA is no longer generated and the 
contractile ring fails to form (Kamijo et al., 2006; Nishimura and Yonemura, 2006; Yüce et al., 
2005; Zhao & Fang, 2005). Until recently, the prevailing model was that Cyk4-binding recruits 
Ect2 to the central spindle, where it helps spatiotemporally activate Ect2 to generate active RhoA 
at the overlying membrane. However, studies showed that the membrane-binding domains of Ect2 
and Cyk4 are essential for GEF activity, while the central spindle itself is dispensable (e.g. via 
depletion of core regulators of central spindle assembly such as PRC1) (Kotýnková et al., 2016; 
Mollinari et al., 2005; Yüce et al., 2005). It is still not known how or where the Cyk4-Ect2 complex 
forms, and how it can generate RhoA in such a well-defined zone. Ect2 localizes to the central 
spindle and equatorial cortex in mammalian cells, but is primarily at the anterior cortex in one-cell 
C. elegans embryos, while neither Cyk4 or MKLP1 are detectable at the cortex in most cells 
(Basant & Glotzer, 2018; Yüce et al., 2005). Recently, Cyk4 was shown to localize to the plus-
ends of bundled astral and/or central spindle microtubules where it colocalizes with cortical Ect2 
in Drosophila S2 cells (Verma and Maarsca, 2020). While this does not explain how the complex 
transitions from microtubules to the cortex, having them in close proximity could facilitate their 
movement via other proteins. 
Aurora B kinase also influences ring assembly. Aurora B kinase is part of the chromosomal 
passenger complex (CPC) which transitions from the kinetochores to the central spindle, and helps 
mediate central spindle assembly (Basant et al., 2015; Basant & Glotzer, 2018; Fededa & Gerlich, 
2012; Guse et al., 2005). During anaphase, Aurora B kinase phosphorylates MKLP1, which is 
required for generating a stable midbody (Douglas et al., 2010; Guse et al., 2005; Figure 3). 
Clustering of the centralspindlin complex is inhibited by the binding of 14-3-3 protein to MKLP1, 
preventing its localization to the central spindle. Additional studies found that Aurora B kinase 
phosphorylation to MKLP1 antagonizes 14-3-3 binding, resulting in the clustering and localization 
of centralspindlin to the central spindle (Basant et al., 2015; Douglas et al., 2010). Although less 
clear, this may also occur at the overlying cortex. A recent study showed that the Aurora B 
kinase/14-3-3 regulation of centralspindlin could influence the generation of active RhoA at the 
equatorial plane for furrowing. In one-cell C. elegans embryos or cultured human cells treated with 
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PRC1 RNAi to disrupt central spindle assembly, contractile rings still form and ingress, and there 
is an increase in the cortical enrichment of Aurora B kinase which could generate active RhoA 
through regulating Cyk4-Ect2 complexes (Adriaans et al., 2019). A model was proposed where a 
membrane-specific pool of Plk1-regulated Cyk4-Ect2 complexes facilitate ring assembly, while 
the central spindle pool acts as a sink (Adriaans et al., 2019; Figure 3). 
Astral microtubules negatively regulate cytokinesis by controlling the breadth of RhoA 
localization (Basant & Glotzer, 2018; Green et al., 2012; Werner et al., 2007). Although the 
mechanism is unknown, astral microtubules promote the removal of contractile proteins from the 
polar cortex including RhoA, anillin, and myosin (van Oostende Triplet et al., 2014; Zanin et al., 
2013). Experiments utilizing RNAi or microtubule-targeting drugs to depolymerize microtubules 
caused an increase in the breadth of contractile proteins, while increasing the length or stability of 
astral microtubules caused a more narrow distribution (van Oostende Triplet et al., 2014; Zanin et 
al., 2013). One mechanism is that astral microtubules control the distribution of contractile proteins 
through anillin, which directly binds to microtubules (Tse et al., 2011; van Oostende Triplet et al., 
2014). Depleting anillin in cells with increased length or stability of astral microtubules restores 
the normal breadth of contractile proteins (van Oostende Triplet et al., 2014). In addition, there is 
an increase in anillin localization to microtubules when the levels of active RhoA are decreased, 
suggesting that there is a negative correlation between RhoA vs. microtubule-binding (van 
Oostende Triplet et al., 2014). However, the mechanism by which anillin facilitates the clearance 
of contractile proteins from the poles is unknown. A recent study showed that the activation of 
Aurora A kinase at astral microtubules by TPXL-1 (C. elegans TPX2), which is a microtubule 
associated protein required for mitotic spindle assembly, facilitates the clearance of anillin and 
myosin from the cell poles in the early C. elegans embryo (Mangal et al., 2018). The relative 
contribution of astral microtubules vs. central spindle to defining the equatorial plane varies 
depending on cell-type and organism (Glotzer, 2017; Ozugergin & Piekny, 2020; Tse et al., 2011). 
One hypothesis is that astral microtubules could be more predominant than the central spindle in 
cells where the central spindle is smaller and located further from the cortex, and could explain 
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Figure 3. The role of the central spindle in initiating cytokinesis. The bundling and assembly 
of the central spindle requires PRC1 and centralspindlin (MKLP1+Cyk-4). MKLP1 and Cyk-4 get 
phosphorylated by Aurora B kinase and Plk1, respectively. Centralspindlin is required to create an 
active zone of RhoA at the region of contractility. Specifically, phosphorylated Cyk-4 activates 
Ect2 (RhoA GEF) which generates RhoA-GTP. Active RhoA initiates actomyosin assembly and 
contractility. A model was recently proposed where Plk1 inhibition to PRC1 and Aurora B kinase 
work redundantly to create a pool of centralspindlin at the cortex to initiate cytokinesis (Adriaans 

























1.3 Spindle-independent pathways 
Microtubule-independent mechanisms have also been shown to spatially regulate 
cytokinesis. Signals arising from different subcellular locations affect the localization of 
contractile proteins. For example, the cortical protein M phase GTPase activating protein (MP- 
GAP), which is a GAP that promotes hydrolysis of GTP to inactivate RhoA, works with astral 
microtubules to globally inactivate and restrict active RhoA to the equatorial cortex in mammalian 
cells and the one-cell C. elegans embryo (Zanin et al., 2013). In addition, active Rac may be 
reduced at the equatorial cortex to facilitate the formation of long branched F-actin via RhoA. 
Although this is heavily debated in the field, Cyk4 has GAP activity toward several Rho-family 
GTPases in vitro. While it is required for RhoA activation via Ect2-binding in cells, its GAP 
domain could downregulate Rho GTPases in the equatorial plane. However, it is not clear that this 
occurs in vivo. RNAi of ced-10 (C. elegans Rac) or arp-2/3 (regulates branched F-actin assembly) 
partially suppresses cyk-4 RNAi to permit some furrowing (Canman et al., 2008). However, this 
could be interpreted in two very different ways. One interpretation is that CYK-4 is required to 
downregulate CED-10, and loss of CYK-4 causes hyperactive CED-10, which is suppressed when 
reduced. Another interpretation is that CED-10 is required to control rigidity of the polar cortex, 
and its reduction softens the cortex to permit furrowing when the contractile ring is improperly 
formed (Canman et al., 2008). Signals also come from other subcellular locations. A kinetochore-
derived pathway was recently shown to induce relaxation of the mitotic polar cortices in cultured 
mammalian and Drosophila cells. This is accomplished through a kinetochore-tethered PP1 
phosphatase-Sds22 complex which dephosphorylates the ezrin/radixin/moesin (ERM) proteins 
and reduces F-actin crosslinking for relaxation of the polar cortex (Rodrigues et al., 2015). In 
addition, several studies have shown a correlation between the chromatin position and spatial 
distribution of contractile proteins in mammalian cells, suggesting the presence of cues emitted 
from chromatin to regulate cytokinesis (Beaudet et al., 2017, 2020; Kiyomitsu & Cheeseman, 
2013; Rodrigues et al., 2015). 
1.4 The chromatin pathway 
A gradient of active Ran is a radar that informs the cell about chromatin position during 
mitosis. Although Ran is best known for its role in nucleocytoplasmic transport, it has a well-
described function for regulating spindle assembly and kinetochore attachment during metaphase, 
and more recently we uncovered a role for Ran during cytokinesis. The Ran GEF (RCC1) is 
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tethered to histones of chromatin where it generates Ran-GTP, while Ran-GAP is enriched in the 
cytosol to form inactive Ran-GDP at distances away from chromatin (Clarke & Zhang, 2008; Xu 
& Massagué, 2004). Ran-GTP binds to and removes importin alpha/beta heterodimers from the 
nuclear localization signal (NLS) of proteins (Clarke & Zhang, 2008; Kalab & Heald, 2008; Soniat 
& Chook, 2015). During metaphase, Ran-GTP dissociates importins from spindle assembly factors 
to initiate the formation of a bipolar spindle around chromatin (Forbes et al., 2015; Kalab & Heald, 
2008). The model for how this works is that proteins required for spindle assembly are inactive 
when bound to importins, but when importins are removed, they are able to form active complexes 
to mediate spindle assembly (Ozugergin and Piekny, 2020). This ensures that a bipolar spindle 
builds around the chromosomes, and can modulate kinetochore attachments. 
During meiosis, chromatin position controls polar body formation to extrude the excess 
chromosomes. Proteins that form an actin cap, a structure that acts as a precursor to polar body 
extrusion, accumulate at precise distances away from chromatin and Ran-GTP. Experiments 
showed that the location of polar body formation changed in response to DNA beads of different 
sizes (Deng et al., 2007). Thus, Ran-GTP and the inverse gradient of importins were proposed to 
function as a molecular ruler where optimal concentrations facilitate cortical polarization, but 
inhibit it at other concentrations (Deng et al., 2007).  
During cytokinesis, the Ran pathway regulates cortical polarity via a model that is 
reminiscent of its control of polar body formation vs. spindle assembly. Our lab and others found 
that chromatin position inversely correlates with the localization of contractile proteins during 
cytokinesis (Kiyomitsu & Cheeseman, 2013; Beaudet et al., 2017; Figure 4). In addition, in cells 
lacking polymerized microtubules and stimulated to exit mitosis, anillin and myosin localized 
away from chromatin but not when RCC1 (RanGEF) activity was reduced (Kiyomitsu & 
Cheeseman, 2013). In cells with intact spindles, reducing RCC1 function during cytokinesis 
caused the ectopic localization of contractile proteins and failed ingression, while the membrane-
localization of exogenous active Ran caused proteins to move away from the furrow and 
displacement of the ring (Beaudet et al., 2017). This data supports a role for the Ran pathway in 
spatial regulation of the contractile ring for cytokinesis. Our lab also found that anillin is a direct 
target of this pathway (Figure 4). Anillin has a conserved binding site for importins in its C-
terminus, and importin-binding is required to facilitate its cortical localization and function for 





















Figure 4. Importin- gradient during cytokinesis. High importin- gradient (dark orange) is 
inversely correlated with high Ran-GTP gradient (pale yellow), which is high around chromatin 
and low around the cortex. During anaphase, Importin- binding mediates the recruitment of 
anillin (green) to the equatorial cortex. This represents the chromatin pathway that spatially 
coordinates anillin besides other cytokinesis pathways, including central spindle (pink) and astral 



























1.5 Anillin as a target of the chromatin pathway 
As described above, anillin binds to multiple components of the cell and is a key regulator 
of cytokinesis among metazoans (Green et al., 2012; Piekny & Glotzer, 2008; Piekny & Maddox, 
2010; Figure 5).  Depletion of anillin causes cytokinesis phenotypes which vary depending on the 
cell type and include a switch from asymmetric to symmetric ingression, oscillation of the ring 
due to instability in ring positioning, and failure to form a stable midbody (Hickson & O’Farrell, 
2008; Maddox et al., 2007; Piekny & Glotzer, 2008; Reyes et al., 2014). In the N-terminus, anillin 
has a non-canonical NLS that binds to importins for nuclear localization during interphase (Chen 
et al., 2015). It also has binding sties for F-actin and non-muscle myosin (Figure 5; Field & Alberts, 
1995; Oegema et al., 2000; Straight et al., 2005). Additional binding sites have been identified for 
proteins such as CD2AP, citron kinase, and mDia, among others, although it is not clear what the 
function of these different interactions are (El Amine et al., 2013; Haglund et al., 2010; Piekny & 
Maddox, 2010; Watanabe et al., 2010). Citron kinase-binding is required to retain anillin in the 
midbody ring, while binding to actin and myosin would crosslink the ring to the membrane via 
interactions in the C-terminus (El Amine et al., 2013; Gai et al., 2011; Green et al., 2012; Oegema 
et al., 2000; Piekny & Glotzer, 2008). In the C-terminus, anillin binds to RhoA through the RhoA-
GTP binding domain (RBD), and binds to phospholipids, importin(s), microtubules and Ect2 via 
an adjacent C2 domain (Figure 5; Beaudet et al., 2017; Beaudet et al., 2020; Budnar et al., 2019; 
Frenette et al., 2012; Liu et al., 2012; Sun et al., 2015; van Oostende Triplet et al., 2014). A 
Pleckstrin homology (PH) domain is found at the very C-terminus, and binds to septin filaments 
and phospholipids (Figure 5; El Amine et al., 2013; Green et al., 2012; Liu et al., 2012; Piekny & 
Maddox, 2010). Anillin is recruited by active RhoA and localizes to the equatorial cortex, where 
it can feed back to stabilize RhoA (Beaudet et al., 2020; Budnar et al., 2019; Piekny & Glotzer, 
2008). Although the mechanism is not clear, one model is that anillin promotes the clustering of 
PI4,5P2 lipids that are favored by RhoA, and this influences the residence kinetics of RhoA to 
increase binding to downstream effectors for ring assembly and ingression (Budnar et al., 2019). 
Our recent work has shed light on how inter- and intra-molecular interactions in the C-terminus 
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Figure 5. The molecular structure of anillin. In the N-terminus, a non-canonical NLS is present 
to mediate the nuclear localization of anillin during interphase (pink). Myosin and actin bind to 
their binding domains (BD) on anillin (purple and blue, respectively) to facilitate contractile ring 
assembly and ingression. In the C-terminus, Anillin-homology domain (AHD) consists of RBD 
(magenta) and C2 domains (green). RhoA binds to RhoA-binding domain (RBD). C2 domain 
binds to multiple cytokinesis regulators including microtubules, Ect2, importin-beta, and 
phospholipids. Importin-beta binds to anillin through an NLS that exists on the C2 domain. The 
pleckstrin homology (PH) domain of anillin (yellow) binds to phospholipids and septins. The 























Importin-binding facilitates the recruitment of anillin to the equatorial cortex (Figure 4). 
Our lab found that importin-beta binds to anillin through a conserved NLS in the C2 domain 
(Beaudet et al., 2017; Beaudet et al., 2020; Figure 5). In mammalian cells, point mutations that 
disrupt importin-beta binding results in delayed recruitment to the equatorial cortex, higher off-
rates, and cytokinesis failure. The over-expression of importin-beta also reduces anillin’s 
recruitment to the equatorial cortex (Beaudet et al., 2017). This observation was similar to a 
previous finding in Drosophila embryos, where the over-expression of importin-alpha during 
cellularization caused a decrease in anillin and septin (Peanut) localization (Silverman-Gavrila et 
al., 2008). Cellularization is the process where membranes invaginate between nuclei to form 
compartmentalized cells during development. The authors showed that Peanut binding to anillin 
was competed by importin-alpha in vitro, and that Ran-GTP could promote the removal of 
importin-alpha from anillin (Silverman-Gavrila et al., 2008). The authors proposed a model where 
importin-alpha is released from anillin to permit Peanut binding within the vicinity of the nuclei. 
The major issue with this model is that Ran-GTP would be sequestered in the closed nuclei and 
would not have an opportunity to compete with importin-binding. We propose that their findings 
support our model, where there is an optimal level of importin-binding that facilitates anillin’s 
localization via binding to lipids and septins. If importin levels are too high, they outcompete 
binding to other factors that are required for anillin’s cortical recruitment. 
We also found that there are intramolecular interactions in the C-terminus that control 
anillin’s function. In particular, the RhoA binding domain (RBD) autoinhibits the adjacent C2 
domain, which contains the NLS (Beaudet et al., 2017; Beaudet et al., 2020). The C-terminus of 
anillin does not localize to the nucleus, but the C2 domain is nuclear after removal of the RBD 
(Beaudet et al., 2017; Beaudet et al., 2020). The C-terminus only weakly binds to importins or 
microtubules, but their binding to the C2 domain is much stronger after removal of the RBD 
(Beaudet et al., 2017; Beaudet et al., 2020). We proposed a model whereby active RhoA binds to 
the RBD in anaphase, to relieve the autoinhibition and expose binding sites for other components 
in the C-terminus.  
To summarize, the Ran-GTP gradient ensures robust cytokinesis by creating an inverse 
gradient of importins that coordinates cortical polarity with chromatin position. This chromatin-
sensing pathway works redundantly with other cytokinesis pathways in symmetrically dividing 
cells, and act as a back-up mechanism if other pathways are disrupted. For example, it can spatially 
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regulate cytokinesis if microtubules are perturbed (Beaudet et al., 2017; Kiyomitsu & Cheeseman, 
2013). Previous studies showed that Ran-GTP gradient varies among cell types (Kaláb et al., 2002; 
Kaláb et al., 2006; Kaláb & Heald, 2008). We hypothesize that asymmetrically dividing cells, or 
cells with different ploidy or fate, may have stronger requirements for the Ran pathway.  
1.6 The chromatin pathway and cancer cells 
Cancer cells have aneuploidy and yet divide successfully despite this genomic instability. 
It is not known how this occurs, but studies have shown that factors controlling spindle assembly 
are often upregulated in cancer cells. In particular, RCC1 is overexpressed and/or upregulated in 
many cancers, and cancer cells have a steeper Ran-GTP gradient that correlates with increased 
chromosomal numbers (Hasegawa et al., 2013). They proposed a model where the steeper 
gradients could more strongly control spindle assembly factors, and the complexes required for 
kinetochore attachments. We hypothesize that the steeper Ran-GTP gradient could play a dominant 
role vs. microtubule-dependent pathways in positioning the contractile ring for cytokinesis of 
cancer cells with high aneuploidy (Figure 6). In support of this model, anillin is also overexpressed 
in many cancer cells including those from the liver, pancreas, breast and lung (Hall, 2005; Piekny 
& Maddox, 2010; Wang et al., 2020; Zhang et al., 2018). The depletion of anillin in mice delayed 
or prevented liver tumor progression without affecting the normal function of the liver tissue 
(Zhang et al., 2018). However, since hepatocytes (predominant liver cell type) typically have high 
ploidy due to failed cytokinesis and endoreplication, it is not clear if this would apply to other 
types of cancers. Our knowledge of anillin’s requirement and function for cytokinesis has been 
limited to a handful of model systems. Depletion of anillin in HeLa cells, early Xenopus leavis 
embryos or S2 drosophila cells results in destabilization of the contractile ring and cytokinesis 
failure (Hickson & O’Farrell, 2008; Piekny & Glotzer, 2008; Piekny & Maddox, 2010; Reyes et 
al., 2014). However, depletion of ANI-1 (one of C. elegans anillins) in the one-cell C. elegans 
embryo causes only mild cytokinesis phenotypes where cells ingress symmetrically vs. 
asymmetrically and are sensitized to failure upon perturbation of other cytokinesis components 
(Maddox et al., 2005; Maddox et al., 2007). Interestingly, depletion of ANI-1 causes cytokinesis 
failure of neuroblasts during mid-embryogenesis, but not other cell types (Wernike et al., 2016). 
This suggests that there are different threshold requirements for anillin depending on the organism 
and cell type, reflecting the need to study anillin function in different contexts. We hypothesize 
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that there is a stronger requirement for the chromatin pathway in cancer cells with higher 
aneuploidy, which have steeper Ran-GTP gradients (Figure 6).  
 
1.7 Thesis summary 
To address the role of the chromatin pathway in cells with high ploidy, we characterized 
the requirement of anillin in different cell lines. We used immunofluorescence in multiple cell 
lines to determine the requirement of anillin during cytokinesis. We also generated tools to study 
the role of endogenous anillin in cytokinesis with higher precision than previous methods (Chapter 
3). Until now, we relied on RNAi to knock down anillin, with no way of measuring the extent of 
knockdown in live cells. Different phenotypic severities that likely reflect different requirements 
could simply be due to differences in knock down efficiencies. In addition, we relied on the over-
expression of exogenous constructs to determine the function of different interactions. 
Accordingly, we used CRISPR to generate cultured HCT 116 (colorectal cancer) cells where 
anillin is endogenously tagged with mNeonGreen, and performed anillin RNAi in these cells to 
correlate cytokinesis phenotypes with precise levels of endogenous anillin. 
We also determined the molecular mechanism by which anillin is regulated for cytokinesis 
(Chapter 4). I helped to characterize how the region that lies at the interface of the RBD and C2 
domain is required for intramolecular regulation of anillin for its function in cytokinesis. Since the 
phospholipid-binding and importin-binding sites are close together, I showed that mutations in the 
NLS that disrupt importin-binding do not disrupt phospholipid-binding. Our model is that 
importin-binding may stabilize an open conformation of anillin that facilitates its cortical 
recruitment. This requires that importin has lower affinity for anillin compared to phospholipids 
to support its hand-off to the membrane. Indeed, we previously found that in cells, the over-
expression of importins can inhibit vs. facilitate anillin’s cortical localization. In support of this, I 
found that importins competed with lipids for anillin-binding in vitro. This data provides support 
for our model demonstrating that importin-binding may facilitate cortical recruitment at ideal 
















Figure 6. The requirement of the chromatin pathway in cells with different ploidy. A. On the 
right, a diploid cell showing the contribution of cytokinesis pathways presented by arrows. Signals 
emitted from the central spindle (pink), astral microtubules (navy), and chromatin (blue) regulate 
cytokinesis. In a diploid cell, the pathways work redundantly to regulate cytokinesis. On the left, 
an aneuploid cell showing chromosomal gain (>2n). The chromatin pathway is hypothesized to be 
dominantly contributing to regulate cytokinesis. B. The contribution of different pathways to 
regulate the function and cortical recruitment of anillin. It is hypothesized that cells with higher 
ploidy would rely more heavily on the chromatin pathway (highlighted by a dotted box) to recruit 





















Chapter 2. Materials and Methods 
 
2.1 Cell culture 
HeLa cells were grown and plated in DMEM (Wisent), supplemented with 10% cosmic 
calf serum (CCS; Thermo Scientific), and 2 mM L-glutamine (Wisent). HCT116 cells were grown 
in McCoy’s Medium (Wisent) with 10% CCS. A549 cells were grown in F12K Medium (Wisent) 
with 10% CCS. HFF-1 cells were grown in DMEM, supplemented with 10% fetal bovine serum 
(FBS; Thermo Scientific). Cells were maintained in an incubator of 5% CO2 at 37 °C. 
HCT116, HeLa, A549, and HFF-1 cells were seeded on square or round (No. 1.5) 
coverslips in 6-well plates to reach a confluency of ~50-60%. Coverslips were acid-washed with 
0.1M HCl, then washed and sterilized with isopropanol and air-dried before use. Alternatively, 
cells were plated to a similar confluency in a 35mm µ-dish (Ibidi). The cells were transfected with 
3 uL of 2 nM of anillin siRNA using Oligofectamine (Invitrogen) as recommended by the 
manufacturer’s protocol except we used 9 uL per well in 6-well plates. The following siRNA was 
used to deplete endogenous Anillin; 5’CAUAUAAGUCUAAGGAAU3’ (Dharmacon) as 
described previously (Piekny & Glotzer, 2008). For transfection or co-transfection with DNA, 0.5-
2 ug DNA was added, or combined with the siRNAs, using Lipofectamine 3000 or 2000 
(Invitrogen) as recommended by the manufacturer’s protocol, except that 3 uL of reagent was used 
to reduce lethality. Cells were fixed and/or imaged after 24-30 hours. 
 
2.2 Plasmids  
The anillin constructs tagged with GFP (GFP:Anillin; GFP:Anillin (C-terminus) for 
mammalian cell expression or protein expression tagged with MBP or GST (Anillin:MBP; 
Anillin:GST; Anillin:GST (AHD; 608-940); Anillin:GST (C-terminus; 608-1087)) were generated 
previously (Piekny and Glotzer, 2008; Frenette et al., 2012). Myc:Ect2 (C-terminus), 850 KK 851-
DE (the NLS mutant), and A703E; E721A (the RBD mutant) were generated previously (Beaudet 
et al., 2017; Frenette et al., 2012). The 735 LL 736-DD (strong I/F), and the strong I/F + NLS 
mutants were generated in the anillin constructs by quick-change PCR. All constructs were verified 
by sequencing. 
 
2.3 Fixing and immunofluorescence  
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Cells were fixed for immunofluorescence using TCA as previously described (Yüce et al., 
2005). Specifically, cells were first washed with cytoskeletal buffer (80 mM PIPES, 1mM MgCl2, 
5 mM EGTA), then incubated with ice-cold 10% w/v trichloroacetic acid (TCA) at 4 °C for 14 
minutes. The cells were then washed and permeabilized 4 times with 0.3% Triton X-100 
phosphate-buffered saline (0.3% PBST) (pH 7.0). For immunostaining, the coverslips were placed 
in a chamber with wet paper towels to prevent the cells from drying. The cells were blocked with 
5% Normal Donkey Serum (NDS) in PBS-T for 25 minutes prior to adding 1:200 rabbit anti-
anillin (Piekny & Glotzer, 2008) or rabbit anti-GFP antibodies (generously provided by M. 
Glotzer, University of Chicago) and 1:400 mouse anti-alpha-tubulin (DM1A; Sigma-Aldrich) or 
1:100 mouse anti-GFP (Clones 7.1 and 13.1; Roche) primary antibodies for 2 hours at room 
temperature. The cells were then washed 3 times with 0.3% PBS-T and incubated with 1:250 anti-
mouse or anti-rabbit 488 and 1:250 anti-mouse or anti-rabbit 568 (Invitrogen) secondary 
antibodies for 2 hours at room temperature. The cells were then washed and incubated with 1:1000 
of DAPI (1 mg/mL; Sigma-Aldrich) for 5 minutes to stain the DNA, after which they were washed 
once with 0.3% PBS-T followed by a final wash with 0.1 M Tris pH 8.8. After aspiration, pre-
warmed mounting media (4% n-propyl gallate in 50% glycerol, 0.1 M Tris pH 8.8) was added to 
the cells, which were placed on glass slides and sealed by nail polish for imaging.  
 
2.4 Microscopy 
Fixed cells were imaged using two different microscopes. Cells were imaged using the 
Nikon Eclipse TiE inverted epifluorescence microscope with Lambda XL LED light sources. 
Fields of view were acquired using the 60x/1.4 Plan APO oil immersion objective (pixel size 0.27 
μm), using a Piezo Z stage (ASI), a Photometrics Evolve 512 EMCCD camera and Elements 
acquisition software (Nikon), and a Heliphor LED-based source (405, 480, 555nm). Settings were 
established and kept constant based on the control samples (Figures 7 B and 8 A). Cells also were 
imaged using a Leica DMI6000B wide-field microscope with the 63x/1.4 PL APO oil immersion 
objective (pixel size 0.102 μm), and Z-stacks of 1 μm were acquired with a Hamamatsu OrcaR2 
camera and Volocity software (PerkinElmer) using a Piezo Z stage (MadCityLabs) (Figure 13 B). 
All image files with the appropriate Z-stack were exported as TIFFs, which were opened with 
ImageJ (NIH). Merged colour images were then converted into 8-bit images and imported into 
Illustrator (Adobe) to make figures.   
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For live imaging, cells were incubated in the humidified incubator with 40 nM Hoechst 
33342 (Invitrogen) for 30 minutes. Glass coverslips were placed on a 35mm Chamlide magnetic 
chamber (Quorum).  The coverslips were supplemented with 1 mL of corresponding media and 
transferred to the INU-TiZ-F1 humidifier where the temperature of the stage was kept at 37 °C 
and the cover at 40 °C in presence of 5% CO2. For figure 9 C, cells were incubated with 100 nM 
Sir-Tubulin for 3 hours (Cytoskeleton, Inc.) to stain microtubules prior to imaging. Live imaging 
was done on a Ti epifluorescent microscope with a livescan Swept Field confocal unit (Nikon). A 
60x with 1.4 CFI PLAN APOVC oil immersion objective (pixel size 0.27 μm) lens was used. 
Imaging of selected cells were set to Z-stacks, using the piezo Z stage nano-Z100 N, of 1 um for 
15 steps above and below the mid-plane for every 9 minutes for 2 hours and 45 minutes (Figure 9 
C and 10). The iXON897 EMCCD Camera (Andor) was used in presence of Elements acquisition 
software (Nikon) with a slit size of 70 µm with the 488, and 405 lasers which was set for 20% and 
10%, respectively (Figure 10) in addition to the 561 nm laser which was set for 26% laser power 
(Figure 9 C). The exposure time was set in the control to be 200 ms; which was applied to the 
experimental coverslip (Figures 9 C and 10). Movies were analyzed using ImageJ and imported 
into Illustrator (Adobe) to make figures. For Figure 15, images were acquired using the 488 and 
561 nm, lasers (100 mW, Agilent) with 200 ms exposure time which was set between 20-40% 
laser power, depending on the intensity of fluorescent signals (settings were kept constant for 
related experiments), and multiple Z-stacks of 0.5 µm or 1 µm were taken every 60 seconds per 
cell using NIS-Elements acquisition software (Nikon), and a narrow GFP or dual filter (500-544 
and 600-665 nm; Chroma). All of the images co-expressing GFP and mRuby probes were 
spectrally unmixed using the NIS-Elements acquisition software (Nikon). Image files were 
exported as TIFFs, which were opened with ImageJ (NIH) and converted into maximum intensity 
Z-stack projections. Projections and merged colour images were then converted into 8-bit images 
and imported into Illustrator (Adobe) to make figures. 
 
2.5 Quantification 
Fixed interphase cells were used to determine the proportion of mono and binucleate cells. 
Data was analyzed using Excel (Microsoft) and graphed using GraphPad (Prism; Figures 7 and 8). 
To determine the levels of anillin remaining after RNAi for the acquired images in Figure 10, the 
appropriate Z-stack was opened in Image J, and a free-hand shape was drawn around the cell in 
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anaphase to measure the levels (a.u.) of the pixels inside the shape. The average fluorescence 
intensity of the entire siRNA-treated cells was divided by the average fluorescence intensity of the 
non-treated cells. Cells were monitored for cytokinesis phenotypes by determining the time point 
when furrow regression was first observed, and correlated with their levels determined as above. 
Data analysis was done on Excel (Microsoft) and GraphPad (Prism) to make graphs. 
To determine changes of the nuclear localization for GFP:Anillin (C-term; 608-1087) and 
the generated (the NLS; the strong I/F; the NLS + strong I/F) mutants (Figure 13B), 2 ROI’s of 
the nucleus and the cytosol of  each interphase cell were selected. The average fluorescence 
intensity of the ROI of the nucleus was divided by the average ROI of the cytosol. If the ratio (R) 
was above 1.25, the localization was considered nuclear. If R was below 1.25, the localization was 
considered cytosolic (Figure 13C). All data was imported into Excel (Microsoft), where 
calculations were performed including standard deviations and Student’s t tests. Images were 
transferred to Illustrator (Adobe) to make figures. 
To measure the ratio of cortical accumulation vs. cytosol, the average intensity was 
determined in an area drawn around the cortex from one pole to the other (Figure 15). This value 
was then divided by the average fluorescence intensity from the average of 3 ROI’s in the cytosol. 
Similar timepoints were selected for anaphase just before ingression based on time from anaphase 
onset. All data was imported into Excel (Microsoft), where calculations were performed including 
standard deviations and Student’s t tests. All of the images and graphs were transferred to 
Illustrator (Adobe) to make figures. 
 
2.6 Protein purification for binding assays 
The following proteins were made from E. coli BL21 cells: GST, GST:Importin-, 
GST:Anillin (AHD; 608-940), MBP:Anillin (RBD + C2; 672-872), and MBP:Anillin (C-term; 
608-1087), GST:Anillin (AHD; strong I/F mutant; 735 LL 736-DD), GST:Anillin (AHD; NLS 
mutant; 850 KK 851-DE), MBP:Anillin (AHD; strong I/F mutant), MBP:Anillin (AHD; RBD 
mutant; A703E; E721A) were grown to OD600 of 0.4-0.6 at 37 C, then 0.5 M IPTG was added for 
5 hours at 28-29 C, and 200mL was centrifuged at 4 C for 10 minutes. Pellets were resuspended 
with 25 mL cold Tris-buffered saline (TBS), centrifuged, flash-frozen and stored at -80 C. 
Bacteria were resuspended in lysis buffer [2.5 mM MgCl2, 50 mM Tris, 150 mM NaCl pH 7.5, 
0.5% Triton X-100, 1 mM dithiothreitol (DTT), 1 mM phenylmethanesulfonyl fluoride (PMSF) 
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and 1 X protease inhibitors (Roche)], incubated with 1 mg/mL lysozyme on ice for 30 minutes, 
then sonicated three times. Extracts were incubated with pre-equilibrated amylose resin (New 
England Biolabs) or glutathione sepharose 4B (GE Lifesciences) for 5 hours or overnight at 4˚C 
with rotation. After washing with lysis buffer, beads were stored as a 50% slurry at 4˚C or eluted 
in equivalent volumes of 10 mM glutathione (pH 8.0) for GST constructs on ice for 2 hours. 
GST:Importin- was cleaved with 1.5 nM TEV protease enzyme (generously provided by Dr. D. 
Kwan, Concordia University) overnight at 4 C. Protein concentration was determined by running 
samples by SDS-PAGE and measuring the density of bands in comparison to known 
concentrations of BSA and/or by Bradford assay for eluted proteins. 
To monitor protein-protein interactions, proteins from cell lysates after transfection were 
pulled down using the purified recombinant proteins described above. Transfected Hela cells were 
lysed in 50 mM Tris pH 7.6, 150 mM NaCl, 5 mM MgCl2, 0.5% Triton X-100, 1 mM DTT, 1 mM 
PMSF with 1 X protease inhibitors (Roche) and incubated with 5-10 µg of purified MBP-tagged 
anillin or GST-tagged importin- protein on beads at 4°C overnight. After binding, beads were 
washed 3–4 X with 50 mM Tris pH 7.6, 150 mM NaCl, 5 mM MgCl2 before adding SDS sample 
buffer (200 mM Tris-HCl pH (6.8), 8% SDS, 0.4% Bromophenol blue, 40% glycerol, 5% -
mercaptoethanol) to denature the proteins for SDS-PAGE. Gels were wet-transferred to 
nitrocellulose membrane for western blotting. All blots were reversibly stained with Ponceau S to 
show total protein. The blots were blocked with 5% milk for 20 minutes, then incubated with either 
mouse anti-MBP antibodies at a dilution of 1:5000 (New England Biolabs) or 1:2500 mouse anti-
GFP antibodies (see above; Roche) in 1 X PBS-T (0.140 M NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4, 0.5% Triton X-100) for 1-2 hours at room temperature. After washing the 
membrane 3-4 X with 1 X PBS-T, 1:10000 secondary antibodies [anti-rabbit-HRP or anti-mouse-
HRP (Cedarlane) were added as per manufacturer’s instructions in 1 X PBS-T for 1 hour. The 
blots were developed using enhanced chemiluminescence (ECL) western blotting detection 
reagents (GE Amersham) and visualized on a GE Amersham Imager 600. All results from each 
pull down assay were replicated in at least three distinct experiments to ensure reproducibility. 
To assess changes in anillin’s interaction with phospholipids, we used PIP strips (Echelon 
Biosciences). The PIP strips were blocked with 3% skim milk in 0.1% 1 X TBS-T (0.1% Tween 
20) at 4°C overnight. PIP strips were removed from blocking solution and incubated for 2 hours 
at room temperature with 1 g/mL of purified GST (control) or one of the GST-tagged 
 28 
recombinant anillin: GST:Anillin (C-term), GST:Anillin (AHD), GST:Anillin (AHD; strong I/F 
mutant), or GST:Anillin (AHD; NLS mutant). For Figure 16, the PIP strip was incubated with 
1:1.13 molar ratio of importin- and 1 g/mL of the strong I/F for 2 hours at room temperature 
following the pre-incubation of importin- with GST:Anillin (AHD; strong I/F mutant; 735 LL 
736-DD) for 40 minutes at 4 C. After washing 3-4 X with 1X TBS-T, the strips were incubated 
with 1:10000 mouse anti-GST antibodies (Sigma-Aldrich).1:10000 of the secondary antibody 
(anti-mouse-HRP) were then added in 1 X TBS-T for 1 hour. After washing the membranes 3-4 X 
with 1 X TBS-T, the signal was developed using enhanced chemiluminescence (ECL) western 
blotting detection reagents (GE Amersham) and visualised on a GE Amersham Imager 600. 
Images were converted to 8-bit by ImageJ and made into figures using Adobe Photoshop and 




Chapter 3. Results: Determining anillin requirements for 
cytokinesis 
3.1 Anillin requirement varies in different cultured human cell lines 
Anillin is a conserved part of the contractile ring in metazoans, but its requirement for 
cytokinesis seems to vary widely depending on the model organism and/or cell type. However, to 
our knowledge, anillin has only been studied in a few human cell lines, and most of our knowledge 
of human anillin function has been generated in HeLa cells (e.g.;  Beaudet et al., 2017, 2020; Liu 
et al., 2012; Piekny and Glotzer, 2008; Sun et al., 2015; van Oostende Triplet et al., 2014). To 
determine how anillin requirement varies among different human cell types, we performed anillin 
knockdown by RNAi in 1) HFF-1 (human foreskin fibroblasts; modal chromosome number: 46) 
as a model for non-cancer diploid cells, 2) HCT116 (colorectal carcinoma; modal chromosome 
number: 45) as a model for a cancer cell type that has aneuploidy, but is near diploid, 3) HeLa 
(cervical adenocarcinoma, modal chromosome number: 82) and 4) A549 (lung carcinoma; modal 
chromosome number: 66) as cancer cell types with aneuploidy and high net chromosomal 
numbers. We used a fixed-cell immunofluorescence assay to monitor endogenous anillin 
expression and cytokinesis phenotypes in population of cells. In particular, when cells fail 
cytokinesis, they become binucleate, which can be easily visualized using a stain for DNA. We 
also performed a western blot on a population of cells to determine that the levels of anillin were 
knocked down to similar levels among the cell lines. As shown in Figure 7A, anillin levels were 
drastically reduced in all four cell lines compared to the control cell populations. Staining of 
individual cells also revealed a strong reduction in anillin, which is typically nuclear localized in 
interphase cells (Figure 7B). Despite the similar knockdown between different cell lines, we 
observed differences in the proportion of cells that failed cytokinesis. While 22.5% of HFF-1 and 
20.3% of HCT116 cells were binucleate (compared to 2.7% and 7.2% binucleate in the control 
populations, respectively), 63.4% of HeLa and 47.1% of A549 cells were binucleate (Figure 7C). 
This suggests that different types of human cells have different requirements for anillin to support 
successful cytokinesis. In particular, HeLa and A549 cells with higher modal chromosome 
numbers had stronger requirements compared to those with lower numbers, even though HCT 116 
cells are cancerous and have aneuploidy. This experiment was verified by Kamar Raad and I using 
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an analogous approach, where we measured and quantified the breadth of anillin and counted 
binucleate cells in the different cell lines. 
 
3.2 Anillin requirement in HCT 116 cells increases with ploidy 
We found it intriguing that anillin’s requirement for cytokinesis varies between different 
cell types. We propose that anillin, as a target for the chromatin sensing pathway, could be more 
required in cells with higher ploidy because they rely more on this pathway for cytokinesis. 
However, these different requirements could be due to differences in their genetic backgrounds. 
Therefore, we determined if anillin’s requirement for cytokinesis increases in the same cell line 
when ploidy is increased. To do this, we treated HCT 116 cells with cobalt II chloride (CoCl2), a 
hypoxia mimicking agent previously shown to induce an increase in ploidy (Lopez-Sánchez et al., 
2014). A mixed population of cells was treated with anillin siRNAs, then the cells were fixed and 
monitored for cytokinesis failure by counting the proportion of binucleate cells that were: 1) 
similar in size to the parent population, or 2) at least 2-fold larger in size (Figure 8A). Indeed, 
while 11.1% of HCT 116 cells of ‘normal’ size were binucleate, 38.7% of large HCT 116 cells 
were binucleate (Figure 8B). Therefore, the larger HCT 116 cells, which we infer have higher 
ploidy because cells have been shown to scale their size with ploidy (Storchova & Pellman, 2004), 











Figure 7. Anillin requirement varies among different cultured human cell lines. A. Western 
blots show the knockdown of anillin (top panels) in HFF-1, HCT 116, HeLa and A549 cells, with 
tubulin (bottom panels) used as a control to compare loading.  B. Images show fixed cells co-
stained for tubulin (red), anillin (green), and DNA (blue) as indicated. The top panels show control 
cells, which are mononucleate, while the bottom panel shows cells after anillin RNAi, and are 
binucleate. The scale bar is 10 µm. C. A bar graph shows the percentage of mononucleate and 
binucleate cells representing cytokinesis success vs. failure, respectively, for each of the cell lines 
as indicated. For each cell type, 300-400 cells were quantified (N=3 replicates) for control vs. 
RNAi-treatment. Bars show standard deviation. Dr. Su Pin Koh, Brandon Jaunky and Kevin 













Figure 8. Anillin requirement for cytokinesis increases with ploidy. A. Images show fixed HCT 
116 cells co-stained for tubulin (red), anillin (green) and DNA (blue). Cells treated with CoCl2 
were either small (original ploidy) or large (higher aneuploidy). The left column shows control 
cells and the right column shows cells after anillin depletion. The scale bar is 10 µm. B. A bar 
graph shows the proportion of mononucleate (successful cytokinesis) and binucleate (failed 
cytokinesis) CoCl2 -treated small or large HCT 116 cells for control vs. anillin RNAi. For each 
treatment, 300 cells were quantified (N = 2 replicates for control, N = 3 replicates for anillin 





3.3 Tagging endogenous anillin in HCT116 cells 
While our data supports different anillin requirements for cytokinesis in different cell types 
and with different ploidy, there were several caveats to this data. Western blots can report for 
RNAi efficiency in a population of cells, but not individual cells where it can be more variable. 
Immunofluorescence can report more accurately for RNAi efficiency within individual cells, but 
requires cells to be fixed and stained, which can introduce variability and artefacts, and only 
reflects an ‘end-point’ of cytokinesis failure. To overcome this problem, we endogenously tagged 
anillin in HCT 116 cells with the fluorescent protein mNeonGreen using CRISPR-Cas9. The 
methodology to do this is shown in Figure 9A and B. The target site that was used as the guide is 
shown in red, while the mNeonGreen sequence is shown in green, and the anillin coding region is 
shown in blue. The repair template used to insert mNeonGreen is shown along with anillin 
homology arms on either side of the insert. Potential clones were recovered, screened for 
homozygosity and sequenced to ensure that the fluorescent protein was properly incorporated 
without introducing mutations. The localization of endogenous mNeonGreen-tagged anillin 
localized similar to what we had previously described for the localization of anillin via antibody 
staining in fixed cells, and for transgenic probes in other cultured human cell lines (Figure 9C; 
(Beaudet et al., 2017, 2020; Piekny & Glotzer, 2008; van Oostende Triplet et al., 2014)). Anillin 
accumulates at the equatorial plane during mid-late anaphase, and subsequently to the ingressing 
contractile ring and midbody (Figure 9C). This localization is in line with prior experiments 
showing its requirement in contractile ring positioning, ingression and in midbody formation 
(Beaudet et al., 2017, 2020; Field & Alberts, 1995; Hickson & O’Farrell, 2008; Liu et al., 2012; 
Oegema et al., 2000; Piekny & Glotzer, 2008). 
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Figure 9. Endogenous tagging of anillin in HCT116 with a fluorescent protein. A. A schematic 
that shows the insertion of the repair template containing mNeonGreen gene using CRISPR-Cas9 
approach into the human genome at the N-terminus of ANLN gene. The insertion happens 
following the Cas9 cleavage at the CRISPR target site which is represented by red arrows. B. DNA 
sequence of the CRISPR target site shown in red, the mNeonGreen DNA sequence shown in green 
and Anillin coding sequence shown in blue. C. Time lapse images of endogenously tagged anillin 
HCT116. Tubulin is shown in red (Sir-Tubulin), Anillin in green and DNA in blue (Hoechst). 




3.4 A defined threshold of anillin is required to support cytokinesis in HCT 116 cells 
With a tool in hand to measure endogenous anillin, we next wanted to use this tool to 
determine anillin’s requirement in HCT 116 cells with more temporal and spatial precision. Cells 
were imaged approximately 24 hours after anillin depletion, when levels are optimally reduced 
(Piekny & Glotzer, 2008). We imaged metaphase cells every 9 minutes, and for up to 3 hours to 
ensure we would capture the completion of cytokinesis. I observed two cytokinesis failure 
phenotypes when anillin levels were considerably reduced in cells, with examples of each 
phenotype shown in Figures 10 A and B. In a subset of cells, the ring ingressed but regressed soon 
after ingression, while in the other subset the ring remained ingressed for an extended period of 
time and subsequently regressed (Figure 10). I quantified this data to determine if there was a 
correlation with anillin levels and the severity of the phenotype observed. As expected, 100% of 
control cells successfully completed cytokinesis (n=50). After performing anillin RNAi (n=59), I 
found that as long as cells had levels of anillin >15%, they could undergo successful cytokinesis 
(n=16/59; representing 27% of anillin RNAi treated cells) (Figure 11A). However, when cells had 
<15% anillin (n=43/59), 51% cells failed cytokinesis (n=30/59) and 22% succeeded cytokinesis 
(n=13/59; Figure 11A). Of the cells that failed cytokinesis, 23% had the early regression 
phenotype, while 77% showed the late regression phenotype (Figure 11B). Interestingly, when the 
anillin levels were measured specifically in cells that had <15% anillin (n=43), there was no 
difference in the remaining levels and cytokinesis failure phenotypes observed (Figure 11C).  For 
example, cells with <2% remaining anillin showed early or late regression (Figure 11C). The 
mononucleate cells with <15% anillin that succeeded cytokinesis, had at least 5% anillin (Figure 
11C). Therefore, we now know that the absolute threshold amount of anillin required to support 
cytokinesis in HCT 116 cells is 5%, and the ideal threshold is above 15%. This precise way of 
measuring anillin’s requirement for the different stages of cytokinesis can help us determine how 













Figure 10. Different cytokinesis phenotypes occur in anillin-depleted HCT 116 cells. A. Time-
lapse images show endogenously tagged HCT 116 cells where anillin is shown in green and DNA 
is shown in blue (stained with Hoechst), with DIC images of the cell underneath (cell outlined in 
yellow-dotted line). The times are shown in minutes and seconds. The top panel shows a control 
cell, and the bottom panel shows an anillin-depleted cell, with the early regression phenotype. 
Cartoon schematics show the early regression phenotype where the ring regresses shortly after 
ingression (chromatin in blue, astral microtubules in purple, central spindle microtubules in pink, 
contractile ring in green and centrosomes in grey). B. The top panel shows the same control cell 
as in A. The bottom panel shows another anillin-depleted cell that shows the late regression 
phenotype. Cartoon schematics show the late regression phenotype where the ring regresses after 














Figure 11. Threshold levels of anillin are required for cytokinesis in HCT 116 cells.  A. A bar 
graph shows the proportion of control (n=50) or anillin-depleted cells that succeeded or failed 
cytokinesis with > 15% anillin levels, or 15% or less of anillin levels (n= 59). B. A bar graph 
shows the proportion of early regression (23%) and late regression (77%) phenotypes in cells that 
failed cytokinesis from A. C. A scatter plot shows the relative levels of anillin for individual cells 


























Chapter 4. Results: Determining the mechanism by which the 
chromatin pathway regulates anillin function for cytokinesis 
*Some of this data was published in: Beaudet et al., 2020. 
We found that a chromatin-sensing pathway regulates cytokinesis by controlling 
contractile ring positioning. Anillin contains a conserved NLS in its C-terminus that binds to 
importin-beta, and mutating this site and disrupting this binding prevents anillin’s cortical 
recruitment during anaphase, and causes cytokinesis phenotypes. We also found that there is 
intramolecular inhibition between the RBD (RhoA-binding domain) and neighbouring C2 domain 
where the NLS is located, along with binding sites for other proteins and components of the cell 
including phospholipids and microtubules. Our model is that RhoA-GTP binding is required to 
make the C2 domain accessible for binding to its interactors, which would ensure that anillin 
function is temporally coordinated with cell cycle exit and when Ect2 becomes active. Then, 
importin-binding helps stabilize this open conformation of anillin, which hands-off to 
phospholipids or microtubules that likely have a higher affinity for anillin. To test this, we needed 
to demonstrate that mutating the NLS does not directly impact phospholipid binding per se, since 
both regions contain basic residues and are close together. Then, we asked if the amino acids that 
lie at the interface between the RBD and C2 domains are required for interactions in the C2 
domain, and the importance of controlling this interface for anillin function. 
 
4.1 Mutating the NLS does not affect phospholipid-binding 
Previous studies showed that the C2 domain can bind to PI4,5P2 phospholipids (Sun et al., 
2015; Budnar et al., 2019). Because the NLS is in close proximity to the putative lipid-binding 
site, which also relies on a stretch of basic residues, we wanted to ensure that mutations in the NLS 
did not disrupt lipid-binding. I compared the phospholipid-binding profiles of recombinant control 
GST:anillin RBD + C2 domains, with the NLS mutant (850 KK 851-DE) and GST:anillin C-
terminus (RBD+C2+PH domains) using strips blotted with a variety of lipids including mono, di-
, and triphosphorylated (3,4,5) phospholipids. As shown in Figure 12, I saw an enrichment of 
binding to PI3P, PI4P and PI5P, with weak signals at PI3,5P2, PI4,5P2 and PI3,4,5P3. The NLS mutant 
retained binding to the same lipids, supporting that these mutations do not disrupt the 
phospholipid-binding site. However, we were surprised to see enrichments of anillin that included 
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PI3P, PI4P, PI5P and PI3,5P2, which had not been previously reported. We previously saw that the 
C-terminus of anillin collected from cell lysates bound preferentially to PI3,4P2, PI4,5P2 and PI3,4,5P3 
(Frenette et al., 2012). To our surprise, adding the PH domain, by testing the binding of anillin C-
terminus to phospholipids, had no effect on the observed lipid profile. In the cell, anillin is bound 
to RhoA, which has a preference for PI4,5P2 lipids (although we previously also saw binding to 
PI3,4P2 and PI3,4,5P3; Budnar et al., 2019; Frenette et al., 2012; Liu et al., 2012; Sun et al., 2015), 
which could influence anillin’s accessibility to this pool vs. other lipids. 
 
4.2 Mutations at the interface of RBD and C2 domains relieve the autoinhibition of the C2 
domain by the RBD  
RhoA and importin binding have been shown to mediate the cortical recruitment of anillin 
(Beaudet et al., 2017; Budnar et al., 2019; Piekny & Glotzer, 2008). However, how RhoA and 
importin-binding are coordinated for the recruitment of anillin is unclear. As described above, the 
RBD autoinhibits the adjacent C2 domain, and we propose that RhoA-binding is required to relieve 
this inhibition and make the C2 domain accessible to importin-binding, which in turn stabilizes 
the open conformation of anillin. To test this, we created point mutations in residues found at the 
interface of the RBD and C2 domain (735LL736-DD; strong interface (I/F) mutant; Figure 13A). 
Based on their position, these mutations should reduce binding between the αB helix and the C2 
domain to strongly disrupt the interface, without affecting RhoA-binding (Figure 13A; Sun et al., 
2015). 
First, we assessed how the strong I/F mutations affect autoinhibition of the NLS in the C2 
domain. To do this, we measured changes in the nuclear localization of different anillin C-terminal 
constructs in interphase HeLa cells. We previously showed that the C-terminus of anillin is not 
localized to the nucleus during interphase, but is after removal of the RBD (Beaudet et al., 2017). 
I compared the distribution of GFP-tagged C-terminus anillin in interphase cells with constructs 
containing mutations in the NLS, the strong I/F mutant, or both (Figure 13B). Based on relative 
levels, their distribution was categorized as nuclear or cytosolic. In particular, nuclear localization 
was determined by the ratio of the average fluorescence intensity of anillin in the nucleus over the 
average intensity of anillin in the cytosol, where R > 1.25 was considered to be “nuclear” and R < 
1.25 was considered to be “cytosolic” (Figure 13C). As shown previously, the C-terminus 
localized primarily to the cytosol in interphase cells, supporting the autoinhibition model (0% 
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nuclear). As expected, mutating the NLS did not change this localization pattern (0% nuclear). 
However, the strong I/F mutant localized to the nucleus in 64% of the cells, which reverted back 
to the cytosol when the NLS was also mutated (0% nuclear; Figure 13B). Therefore, introducing 
the strong I/F mutations were sufficient to relieve autoinhibition of the C2 domain from the RBD, 
making it accessible for importin-binding and nucleocytoplasmic transport. 
 
4.3. The strong interface mutant causes anillin to have an open conformation 
Next, we determined if the strong I/F mutant causes anillin to have binding properties 
similar to anillin in the presence of active RhoA. As described above, our model is that active 
RhoA binding relieves inhibition of the neighbouring C2 domain, and some of our data supports 
that mutations at the interface similarly relieve this autoinhibition. Using recombinant purified 
MBP:anillin (RBD + C2), the RBD mutant (A703E; E721A – predicted to no longer bind to active 
RhoA; Sun et al., 2015) as a negative control, or the strong I/F mutant, GFP-tagged importin-beta 
was pulled down from cell lysates where the levels of endogenous active RhoA were manipulated 
(Figure 14A). Since Ect2 is the GEF for RhoA, active RhoA was generated by overexpression 
(O/E) of the C-terminus of Ect2 that contains the GEF region [Myc:Ect2 (C-term)], and active 
RhoA was reduced by Ect2 RNAi. In both conditions, Importin-binding was higher for control 
anillin vs. the RBD mutant, showing the importance of RhoA-binding in altering anillin’s affinity 
for importin. Interestingly, the strong I/F mutant bound even more strongly to importin than the 
control. This data suggests that the strong I/F mutant no longer requires RhoA-binding for 
increased accessibility to the NLS of the C2 domain, supporting a model where this mutant causes 















Figure 12. Mutating the NLS does not alter recombinant anillin’s binding to phospholipids. 
A. Cartoons show the domains of the anillin constructs; Anillin C-terminus [608-1087; RBD 
(pink)+C2 domain (green)+PH domain (yellow)], Anillin AHD (608-940; RBD+C2), and NLS 
mutant (AHD-RBD+C2 indicated by ** on the cartoon; 850 KK 851-DE). B. Images show 
immunoblots of PIP strips after incubation with either purified GST, which was used as a negative 
control (left), recombinant purified GST-tagged anillin (AHD – RBD + C2; middle left), or with 
the NLS mutant (AHD – RBD + C2; 850 KK 851-DE; middle right), and recombinant purified 
GST-tagged anillin (C-terminus–RBD+C2+PH; right). The schematic underneath shows the 











Figure 13. The strong I/F mutant relieves autoinhibition between the RBD and C2 domains. 
A.  A ribbon structure shows the intramolecular interface between the RBD (magenta) and the C2 
domain (green). The boxed inset shows the amino acids that form electrostatic and hydrophobic 
interactions at the interface. The amino acids that were mutated to generate a strong I/F mutant are 
positioned in the αB helix and are circled (L735D; L736D). To the right is a cartoon schematic 
illustrating how strong I/F mutations are predicted to disrupt the structure of anillin. B. Images 
show fixed HeLa cells expressing GFP-tagged anillin C-terminus, or the NLS mutant, strong I/F 
mutant, or strong I/F + NLS mutant, stained for GFP (green), tubulin (magenta), and DNA (DAPI; 
blue). Yellow arrows point to cytosol localization, while red arrows point to nuclear localization. 
To the right, the percentage of cytosolic vs. nuclear localization is indicated for each condition. 
Standard deviations are shown (N = 3 replicates, with n = 100–130 cells per replicate for each 
condition) and significance was determined using the unpaired Student’s t test (n.s., not significant; 
***, p < 0.0001). C. Inverted images of fixed interphase HeLa cells immunostained for GFP show 
how anillin was determined to be nuclear vs. cytosolic. The average levels in the red square 
(nucleus) were calculated as a ratio R vs. the average levels in the yellow square (cytosol). If R > 













        
 





















Figure 14. The strong I/F mutant has higher affinity for importin-beta. A. An immunoblot 
showing pull downs of GFP-tagged importin-β from cell lysates overexpressing (O/E) Myc-tagged 
Ect2 C-terminus to generate active RhoA. with purified MBP or MBP-tagged anillin (RBD + C2; 
Ctl) or with RBD mutations that disrupt RhoA binding, or mutations that strongly disrupt the RBD-
C2 interface (the strong I/F mutant). B. An immunoblot showing pull downs of GFP-tagged 
importin-β after Ect2 RNAi to reduce active RhoA, with purified MBP or MBP-tagged anillin 
(RBD + C2; Ctl) or with the RBD mutations or the strong I/F mutant. C. A cartoon schematic 
shows how RhoA-GTP (blue) binding to the RBD (magenta) relieves inhibition of the C2 domain 
(green; NLS is indicated) to enable importin-α/β (orange) binding to the NLS (PH domain is in 
yellow). Mutations that strongly perturb the intramolecular interface (strong I/F mutant) remove 
autoinhibition of the RBD, causing importin to bind more strongly to anillin regardless of RhoA 
binding. I helped perform parts of the experiment with Daniel Beaudet and Nhat Pham. 
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4.4 The interface between the RBD and C2 domain is required for anillin’s cortical 
recruitment and function during cytokinesis 
Next, we determined how disrupting the interface affects the localization and function of 
anillin during cytokinesis. To do this, we imaged HeLa cells depleted of endogenous anillin and 
co-expressing mCherry:tubulin and RNAi-resistant GFP-tagged full-length anillin as a control or 
containing the strong I/F mutations during cytokinesis (Figure 15). Full-length anillin localized 
similar to the C-terminus as previously described and all cells completed ingression (100%), while 
the strong I/F mutant failed to localize to the cortex and 62.5% of the cells failed to ingress (Figure 
15). This data shows that the strong I/F mutations abolished anillin’s recruitment to the cortex, and 
failed to support anillin’s function during cytokinesis. Since we previously observed that the 
overexpression of importin-beta caused a decrease in anillin’s cortical localization, we propose 
that the stronger affinity for importin-beta-binding to the strong I/F mutant makes it unable to 
compete with phospholipids for its localization at the membrane.  
4.5. Importin-beta binding seems to decrease the affinity of anillin for phospholipids 
Our data shows that residues interface between the RBD and the C2 domain are required 
to control anillin’s cortical recruitment and function during cytokinesis. Our model for how 
importin-binding regulates anillin’s localization and function is that it stabilizes an open 
conformation, but binds with relatively low affinity that permits hand-off to other interactors. We 
found that the strong I/F mutant binds more strongly to importin-beta compared to control anillin, 
which could out-compete anillin’s ability to bind to these other interactors. In particular, RhoA 
and phospholipids bind cooperatively to anillin to facilitate its cortical enrichment, and if importins 
out-compete binding to phospholipids, this would prevent anillin’s cortical accumulation. To test 
this model, I determined if the strong I/F mutant had a different affinity for phospholipids in the 
presence of importin-beta. Using the lipid strips described earlier, I added recombinant purified 
GST-tagged anillin (RBD + C2) with the strong I/F mutations and found that the phospholipid 
binding profile was similar to what I had seen with control anillin (Figures 12 and 16). However, 
pre-incubation of the strong I/F mutant with recombinant purified importin-beta caused ~43% 
decrease in its affinity for PI5P (Figure 16). Although preliminary, this data suggests that importin-
beta binding to the strong I/F could compete with anillin to binding to phospholipids, and supports 
a model where optimal importin-binding facilitates anillin function, but tipping the balance of this 







Figure 15. The interface between the RBD and the C2 domain is required for anillin’s 
cortical recruitment and function during cytokinesis. Time-lapse images show HeLa cells 
treated with anillin RNAi and co-expressing RNAi-resistant GFP-tagged full-length control (n = 
15) or strong I/F mutant anillin (n = 16; green) and mCherry:tubulin (magenta). The percentage of 
cells that failed to complete ingression are indicated. Times are shown in minutes from anaphase 









Figure 16. Importin-beta competes with phospholipids for strong I/F mutant binding. A. A 
cartoon schematic of the open conformation of anillin caused by the strong I/F (indicated by ^^) 
in the presence and absence of importin-beta (anillin-AHD; RBD (pink) + C2 domain (green)). B. 
Images of immunoblots show lipid strips after incubation with GST-tagged strong I/F mutant 
(AHD), and in the presence of importin-beta. Different exposure times (10 seconds, left; 0.1 
seconds, right) are shown to highlight the relative changes in phospholipid-binding (PtdIns(5)P is 





































Chapter 5. Discussion 
 
This thesis sheds light on 1) how the requirement for anillin varies among different cell 
types, and 2) the intramolecular regulation of anillin by importin binding during cytokinesis. The 
tight spatiotemporal regulation of cytokinesis is accomplished by multiple pathways that work 
redundantly to avoid cytokinetic errors. While the spindle-dependent pathways are relatively well-
studied, spindle-independent pathways are under-explored. Our lab and others found a novel 
chromatin pathway that utilizes the mitotic Ran-GTP gradient to regulate cytokinesis (Beaudet et 
al., 2017, 2020; Kiyomitsu & Cheeseman, 2013). This pathway senses chromosomes to properly 
position the contractile ring and prevent aneuploidy. While Ran-GTP levels are high around 
chromatin, there is an inverse gradient of importins that are free to bind NLS-containing proteins 
near the cortex. We found that importin-beta binds to anillin to facilitate its recruitment to the 
equatorial cortex (Beaudet et al., 2017, 2020). Since the majority of our knowledge of mammalian 
cell cytokinesis was generated using HeLa cells, it is not clear how the different pathways control 
cytokinesis in different cell types. Specifically, growing evidence suggests that the mechanisms 
controlling cytokinesis vary widely between different cell types, and there is a need to study 
cytokinesis in different contexts (Davies et al., 2018; Herszterg et al., 2014; Ozugergin & Piekny, 
2020). Anillin acts as a hub to coordinate multiple pathways and regulators, making it an ideal 
protein to study cytokinesis mechanisms. In this thesis, we show that anillin has different 
requirements in different cultured human cells, and develop a tool to precisely measure 
endogenous anillin levels. We also uncovered the mechanism by which importin binding mediates 
the cortical recruitment of anillin during cytokinesis.  
In Chapter 3, the overall goal of the study is to determine the requirement of anillin in 
different cell types. We propose that this requirement varies partly with ploidy, as one of the 
mechanisms that regulates cytokinesis involves chromatin-sensing. As mentioned above, the Ran-
GTP gradient is steeper in cells with greater aneuploidy compared to those that are closer to diploid 
(Hasegawa et al., 2013). Interestingly, anillin has been reported to be overexpressed in different 
cancer types and is considered a marker of poor clinical prognosis for several cancers including 
those of the pancreas, lung, breast and liver cancers (e.g., Hall, 2005; Piekny & Maddox, 2010; 
Wang et al., 2020; Zhang et al., 2018). As described in the introduction, anillin depletion in mouse 
models of hepatocellular carcinoma prevented tumor progression without disrupting liver function 
(Zhang et al., 2018). However, it is not clear why anillin is upregulated, and if this expression is 
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to support cytokinesis or other cellular processes. We hypothesized that as a target for the 
chromatin pathway, anillin may be upregulated in cells with greater aneuploidy to support their 
successful cytokinesis and avoid mitotic catastrophe. We investigated the role of anillin during 
cytokinesis in cells with different types of aneuploidy. Depletion of endogenous anillin showed a 
correlation between the proportion of cells that failed cytokinesis and the ploidy of the cells (Figure 
7). This suggests that anillin may have different thresholds of requirement in cells with higher 
aneuploidy. However, variability could arise due to differences in RNAi efficiency or genetic 
differences. Thus, we induced increased aneuploidy in HCT116 cells and found that there was a ~ 
3-fold increase in cytokinesis failure (Figure 8). This supports our hypothesis that there is a higher 
threshold for anillin in cells with higher chromosomal numbers. These results are exciting as they 
reveal that cancer cells with high aneuploidy could rely more heavily on anillin to avoid mitotic 
catastrophe, making it ideal to target as an anti-cancer therapy. However, our data relied on western 
blots and fixed cell immunofluorescence to visualize changes in endogenous anillin, which lack 
resolution (e.g. population vs. single cell, or temporal) and cannot be used to study the phenotypes 
leading to cytokinesis failure.  
Live imaging provides improved spatiotemporal resolution to analyze cytokinesis 
phenotypes. Tagging proteins with fluorophores facilitates the optical tracking of protein 
localization. Although transgenic probes are commonly used to visualize proteins, they are 
typically over-expressed, and could differ significantly from endogenous proteins in terms of their 
interactions and localization (Bukhari & Müller, 2019; Mahen et al., 2014). Hence, using gene-
editing tools such as CRISPR-Cas9 to tag the endogenous protein is ideal. We used CRISPR-Cas9 
to endogenously tag anillin in HCT116 cells with mNeonGreen, a bright and stable fluorescent 
protein (Shaner et al., 2013; Figure 9). The endogenous tag enabled us to more accurately 
determine anillin’s requirement in these cells with high spatiotemporal resolution (Figure 10). We 
found that the absolute minimum threshold of anillin required to support cytokinesis was 5% 
compared to control levels, but 15% of anillin was required to support successful cytokinesis 100% 
of the time. We were surprised to observe two different cytokinesis phenotypes, early regression 
and late regression, with no obvious difference in the levels associated with one phenotype vs. the 
other (Figure 11). Anillin was shown to regulate the contractile ring to midbody transition in 
Drosophila S2 cells, but a later phenotype has not been described before to our knowledge (Kechad 
et al., 2012). It would be interesting to determine what role anillin has in midbody stabilization 
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and/or abscission. This data also suggests that HCT 116 cells have redundant mechanisms that can 
support cytokinesis when only very little anillin remains. This is quite different compared to what 
has been reported for anillin requirement in HeLa cells, where the majority of cells fail cytokinesis 
upon anillin depletion, and these cells presumably have similar levels of anillin remaining 
(Beaudet et al., 2017; Piekny & Glotzer, 2008; van Oostende Triplet et al., 2014). Our lab recently 
tagged endogenous anillin with mNeonGreen in HeLa cells and will perform a similar study. We 
also plan to increase ploidy in the tagged HCT 116 cells to determine how the threshold 
requirements for anillin. In addition, it would be ideal to visualize the Ran-GTP gradient in these 
cell lines using an established FRET probe that would provide a direct read out for the correlation 
between anillin requirement, ploidy and the Ran-GTP and/or importin-gradient (Hasegawa et al., 
2013; Kalab & Heald, 2008). These data would support considering anillin as a therapeutic target 
for cancers that have gained aneuploidy.  
In Chapter 4, we explored the intramolecular regulation of anillin by importin-binding. 
Previously, our lab found that anillin is regulated by importin-beta binding through an NLS that is 
adjacent to a phospholipid-binding site in the C2 domain (Figure 5). Mutating the NLS resulted in 
a delayed recruitment and a decrease of breadth of anillin (Beaudet et al., 2017). Since the NLS 
and phospholipid-binding sites are close to one another, and both rely on basic residues to mediate 
interactions, I determined that the NLS mutations did not disrupt phospholipid-binding (Figure 
12). Thus, the phenotypes we observed with the NLS mutant were indeed due to loss of importin-
binding. Surprisingly, we observed a strong preference for binding of the AHD or AHD NLS 
mutant to PI3P lipids, although it was previously reported that the lipid-binding site in the C2 
domain binds preferentially to PI4,5P2 lipids (Budnar et al., 2019; Sun et al., 2015). The C-terminus 
of anillin also contains a PH domain, and this domain alone or in combination with the AHD also 
has been shown to bind preferentially to PI4,5P2 lipids (Frenette et al., 2012; Liu et al., 2012). 
Therefore, we expected to observe a shift of lipid preference towards PI4,5P2 when performing the 
in vitro assay with the C-terminus recombinant protein. However, the lipid profile was similar, 
showing a preference towards PI3P (Figure 12). The main difference between our study is the use 
of purified proteins vs. proteins from cell lysates. In cells RhoA binds cooperatively to anillin with 
phospholipids, and may influence the lipid preference of the complex. Therefore, we hypothesize 
that the presence of other interactors in a cell would affect the conformation of anillin and the lipid 
preference when compared to an in vitro assay.  
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Our lab previously found that the C2 domain of anillin is autoinhibited by the adjacent 
RBD domain. We proposed that binding of active RhoA would make the C2 domain accessible 
for importins to bind (Beaudet et al., 2017, 2020). Mutating residues that lie at the interface 
between the C2 and RBD domains (strong I/F) had an increase in affinity for importin-binding. In 
particular, the C-terminus is not nuclear localized due to inhibition via the RBD. However, the C-
terminus with the strong I/F mutations was nuclear localized (Figure 13). Furthermore, the strong 
I/F mutant bound to importin-beta more strongly compared to non-mutant anillin, and regardless 
of the levels of active RhoA (Figure 14). Introducing the strong I/F mutation into full-length anillin 
showed that it prevented anillin from being cortically recruited and from functioning during 
cytokinesis (Figure 15), despite its ability to bind to RhoA (Beaudet et al., 2020). These results 
suggest that the position of the C2 domain relative to the RBD is important. It seems that feedback 
between the two domains is crucial for anillin to perform its function during cytokinesis. We 
hypothesize that although RhoA likely can bind to the RBD in the strong I/F mutant, it binds too 
tightly to importin to be outcompeted by phospholipids and cannot transition to the membrane 
where it is required to support cytokinesis.  
In light of the proposed hypothesis, we tested if importin-beta binding to the strong I/F can 
inhibit phospholipid binding. To do this, we compared the lipid profile of the strong I/F mutant in 
absence and presence of importin-beta. Although preliminary, there seems to be an overall 
decrease in lipid binding of the strong I/F in presence of importin-beta (Figure 16). This suggests 
that the interaction between importin-beta and the strong I/F could decrease the affinity of anillin 
for phospholipids, which could explain why the strong I/F fails to localize or function (Figure 15). 
This is in line with previous observations, where the overexpression of importins decrease the 
recruitment of anillin to the cortex, and support a model where importins only facilitate the cortical 
recruitment of anillin at optimal levels (Beaudet et al., 2017; Silverman-Gavrila et al., 2008). This 
experiment needs to be replicated to validate our observations. Furthermore, using phospholipid 
beads could be more reliable vs. the PIP strips and provide more accurate studies of the effect of 
importin-beta on anillin’s phospholipid-binding. 
Previous studies proposed the presence of a feedback mechanism between the binding of 
RhoA and phospholipids to anillin to mediate its function during cytokinesis (Sun et al., 2015; 
Budnar et al., 2019). Based on our findings, we propose that the importin-binding facilitates the 
cortical recruitment of anillin by stabilizing an open conformation that favours and ‘hands-off’ to 
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phospholipids where it cooperatively binds with RhoA for enrichment at the equatorial cortex 
(Figure 17). In anaphase, active RhoA increases and binds to the RBD to relieve autoinhibition of 
the C2 domain. Importin-beta then binds to the C2 domain to stabilize the open conformation and 
to facilitate interactions between anillin, phospholipids and active RhoA (Figure 17). 
This thesis elucidates the variation of anillin’s requirements in different human cell lines 
and provides a mechanistic insight into the coordinated cortical recruitment of anillin by the 
chromatin pathway and active RhoA. Chapter 3 highlights the need to use better tools to measure 
the requirement of anillin during cytokinesis. In addition, it reflects the need to diversify the use 
of different mammalian cells to determine how mechanisms regulating cytokinesis vary among 
different tissues and contexts. Adapting CRISPR-Cas9 to tag core regulators of cytokinesis can 
reveal threshold requirements in different cell types. Chapter 4 demonstrates the intramolecular 
regulation of anillin by importin-beta. It highlights the coordination of importin-beta, RhoA and 









Figure 17. Proposed model of importin- enhancement to the localization of anillin during 
cytokinesis. (1)  In anaphase onset, RhoA is activated and binds to the RBD (pink) to recruit anillin 
to the equatorial cortex. Active RhoA (blue) increases the affinity of anillin for importin- by 
causing conformational changes between the RBD and C2 domains (green). (2) Near the cortex, 
importin- (orange) binds to anillin through the C-terminal NLS, which (3) feeds back to stabilize 
a conformation that enhances RhoA binding to the RBD by either increasing affinity or reducing 
dissociation. This figure is adapted from (Beaudet et al., 2020). 
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